David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Better Customer Service Should Bolster the Case for Robinhood

By David Moadel, InvestorPlace Contributor

HOOD stock has disappointed some investors, and an ominous threat from the SEC certainly isn't helping. Still, there's good news to report.

Dutch Bros Stock Is Served Up Hot and Fresh, but Not Cheap

By David Moadel, InvestorPlace Contributor

Post-IPO, BROS stock traders are talking about an emerging "Starbucks killer" - but let's first consider if Dutch Bros can compete.

AT&T Stock Should Be in Everyone’s Portfolios

By David Moadel, InvestorPlace Contributor

T stock has fallen despite a robust and visionary outlook from AT&T's CEO, so don't expect the shares to be "dead money" for much longer.

Why Cathie Wood’s Skillz Share Sale Shouldn’t Deter Investors

By David Moadel, InvestorPlace Contributor

It's time to sift through the wreckage of SKLZ stock and discover an underappreciated gem as Skillz introduces new gaming experiences.

Novavax Stock Got Merck-ed, but Don’t Dump Your Shares Now

By David Moadel, InvestorPlace Contributor

NVAX stock still has plenty of value as Novavax has a rich and diverse clinical pipeline, including a promising influenza vaccine candidate.

It’s Time to Rock and Roll with Rocket Companies Stock

By David Moadel, InvestorPlace Contributor

Maybe you never expected Rocket Companies to venture into the solar panel market, but some nice surprises are in store for RKT stock holders.

European Expansion Offers Hope for SmileDirectClub Stock

By David Moadel, InvestorPlace Contributor

SDC stock hasn't brought smiles to investors in 2021, but revenue growth might soon translate to profitability and share-price improvement.

While Canoo Stock Slumps, EV Market Investors Can Jump In

By David Moadel, InvestorPlace Contributor

The beatdown in GOEV stock may be due to Canoo's troublesome bottom-line fiscal stats, but a turnaround could happen down the road.

Break Ground on Advanced EV Profits With Lucid Group

By David Moadel, InvestorPlace Contributor

Now that the Lucid Air is finally being rolled out to the public, it's time for LCID stock to reclaim some of its lost ground in 2021.

ChargePoint Stock Is Priced Wrong, and Will Correct Upwards

By David Moadel, InvestorPlace Contributor

There's a ripe buying opportunity as CHPT stock lags while ChargePoint forges ahead with revenue growth and value-added acquisitions.

Load More